Supplemental
Interest Paid
United Therapeutics Interest Paid decreased by 5.0% to $1.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 64.8%, from $5.40M to $1.90M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows a downward trend with a -4.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementCash Flow Statement
SectionSupplemental
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2017
Last reportedQ4 2025
How to read this metric
Increasing interest payments relative to debt levels may signal rising interest rates or a higher cost of borrowing.
Detailed definition
The total cash outflow for interest payments on debt obligations during the period. This metric highlights the cash cost...
Peer comparison
Used to compare the cost of debt and interest coverage ratios against industry peers.
Metric ID:
interest_paidHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.10M | $4.00M | $4.10M | $4.10M | $5.30M | $8.40M | $11.30M | $13.10M | $14.10M | $14.60M | $14.20M | $12.60M | $10.80M | $9.60M | $7.20M | $5.40M | $4.20M | $1.90M | $2.00M | $1.90M |
| QoQ Change | — | -2.4% | +2.5% | +0.0% | +29.3% | +58.5% | +34.5% | +15.9% | +7.6% | +3.5% | -2.7% | -11.3% | -14.3% | -11.1% | -25.0% | -25.0% | -22.2% | -54.8% | +5.3% | -5.0% |
| YoY Change | — | — | — | — | +29.3% | +110.0% | +175.6% | +219.5% | +166.0% | +73.8% | +25.7% | -3.8% | -23.4% | -34.2% | -49.3% | -57.1% | -61.1% | -80.2% | -72.2% | -64.8% |
Range$1.90M – $14.60M
CAGR-14.9%
Avg YoY Growth+22.1%
Median YoY Growth-13.6%
Interest Paid at Other Companies
Frequently Asked Questions
- What is United Therapeutics's interest paid?
- United Therapeutics (UTHR) reported interest paid of $1.90M in Q1 2026.
- How has United Therapeutics's interest paid changed year-over-year?
- United Therapeutics's interest paid decreased by 64.8% year-over-year, from $5.40M to $1.90M.
- What is the long-term trend for United Therapeutics's interest paid?
- Over 4 years (2021 to 2025), United Therapeutics's interest paid has grown at a -4.5% compound annual growth rate (CAGR), from $16.20M to $13.50M.
- What does interest paid mean?
- The total cash paid for interest on debt.